top of page
Composite picture of lung showing its structure superimposed with a DNA helix

MSCA Doctoral Network LifeLUNG

AstraZeneca

Associated Partner

AstraZeneca logo

AstraZeneca is a global, science-led, and equal opportunities biopharmaceutical business with innovative medicines that are used by millions of patients worldwide. AstraZeneca has its corporate headquarters in Cambridge, UK, and its main R&D centres are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg/Mölndal and Warsaw. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The AstraZeneca Gene Therapy Safety group participating in LifeLUNG is dedicated to the discovery of novel techniques and translatable models for safety assessment of CRISPR applications, as well as other biologics modalities. 

LifeLUNG logo

This project has received funding from the European Union’s Framework Programme for Research and Innovation, Horizon Europe under Grant Agreement No. 101227159 (HORIZON-MSCA-2024-DN-01)

  • Linkedin

Follow us on 

Funded by the European Union
Project funded by Swiss Confederation

©2025 by LifeLUNG. Made with pride by Websters

bottom of page